SCHEMBL2369367

SCHEMBL2369367

C[Si](C)(C)CCOCn1cnc(-c2ccc3ccccc3c2)c1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP11B1 P15538 1/20 0.39
CYP11B2 P19099 1/20 0.39
CDC25A P30304 1/20 0.38
CDC25B P30305 1/20 0.38
CDC25C P30307 1/20 0.38
DUSP3 P51452 1/20 0.38
CYP1A2 P05177 3/20 0.36
DGAT1 O75907 2/20 0.36
SMN1; SMN2 Q16637 2/20 0.35
CYP2C9 P11712 2/20 0.35
CYP2C19 P33261 2/20 0.35
CYP2E1 P05181 1/20 0.35
CYP3A4 P08684 1/20 0.35
CYP2A6 P11509 1/20 0.35
CYP2B6 P20813 1/20 0.35
CHRNB2 P17787 1/20 0.35
CHRNB4 P30926 1/20 0.35
CHRNA3 P32297 1/20 0.35
CHRNA7 P36544 1/20 0.35
CHRNA4 P43681 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1505957 0.87 HPGDS (0.42) DGAT1CYP2C9CYP2C19CYP2E1CYP3A4
SCHEMBL4069982 0.85 HPGDS (0.41) DGAT1CYP2C9CYP2C19CYP2E1CYP3A4
SCHEMBL24229626 0.82 CYP2E1 (0.38) DGAT1CYP2C9CYP2C19CYP2E1CYP3A4
SCHEMBL29019769 0.82 DGAT1 (0.34) DGAT1CYP2C9CYP2C19CYP2E1CYP3A4
SCHEMBL4065195 0.82 MAPT (0.48) CYP11B1DGAT1SMN1; SMN2KDM4EMAPK1
SCHEMBL31106991 0.81 HSD17B1 (0.41) CYP2C9CYP2C19CYP2E1CYP3A4CYP2A6
SCHEMBL24955615 0.81 HSD17B1 (0.41) CYP2C9CYP2C19CYP2E1CYP3A4CYP2A6
SCHEMBL31403194 0.81 DGAT1 (0.39) CYP11B1CYP11B2DGAT1SMN1; SMN2CYP2C9
SCHEMBL4062141 0.80 DGAT1 (0.38) CYP11B1CYP11B2CYP1A2DGAT1SMN1; SMN2
SCHEMBL204155 0.80 SMN1; SMN2 (0.46) CYP1A2DGAT1SMN1; SMN2CYP2C9CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8026265-B2 Heterocycle substituted ketone derivatives as histone deacetylase (HDAC) inhibitors Istituto de Ricerche di Biologia Molecolare P. Angeletti SpA. (IT) 2011-09-27 US disclosed
US-20100234374-A1 Heterocycle Substituted Ketone Derivatives as Histone Deacetylase (HDAC) Inhibitors MSD ITALIA S.R.L. (IT) 2010-09-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100234374-A1 Heterocycle Substituted Ketone Derivatives as Histone Deacetylase (HDAC) Inhibitors HDAC1, HDAC7, HDAC4 CYP11B1 282/4885CYP11B2 441/4885CDC25A 2454/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.